Y-mAbs Therapeutics Ownership 2024 | Who Owns Y-mAbs Therapeutics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

11.46%

Insider Ownership

12.27%

Retail Ownership

76.28%

Institutional Holders

34.00

Y-mAbs Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PARADIGM BIOCAPITAL ADVISORS LP8.84%1.79%3,870,5941,636,98473.29%46,756,776Jun 30, 2024
BLACKROCK INC.6.71%0.00%2,938,71881,4612.85%35,499,713Jun 30, 2024
SOFINNOVA INVESTMENTS, INC.5.01%1.38%2,194,278--26,506,878Jun 30, 2024
VANGUARD GROUP INC4.47%0.00%1,957,339-112,178-5.42%23,644,655Jun 30, 2024
POLAR CAPITAL HOLDINGS PLC4.18%0.13%1,831,000--22,118,480Jun 30, 2024
CORMORANT ASSET MANAGEMENT, LP3.31%1.01%1,450,0001,450,000100.00%17,516,000Jun 30, 2024
D. E. SHAW & CO., INC.2.12%0.01%926,457-141,702-13.27%11,191,601Jun 30, 2024
STATE STREET CORP1.84%0.00%804,61253,5397.13%9,719,713,000Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.75%0.00%765,64322,8943.08%9,250,856Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA1.51%0.01%659,672-86,429-11.58%7,968,838Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.1.48%0.69%647,98277,00013.49%7,827,623Jun 30, 2024
CALIGAN PARTNERS LP1.33%1.64%582,078-5,198-0.89%7,031,502Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP1.11%0.00%484,43165,73215.70%5,852,656Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.84%0.11%369,36022,8496.59%4,461,869Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.0.82%0.01%358,945-1,168,155-76.50%4,336,056Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.80%0.00%349,78467,23323.80%4,225,391Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC0.74%0.01%323,175-279,139-46.34%3,902,000Jun 30, 2024
NORTHERN TRUST CORP0.73%0.00%317,805-3,910-1.22%3,839,084,000Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.58%0.00%255,5955,3702.15%3,087,588Jun 30, 2024
MORGAN STANLEY0.46%0.00%203,14015,0438.00%2,453,932Jun 30, 2024

Y-mAbs Therapeutics's largest institutional shareholder is PARADIGM BIOCAPITAL ADVISORS LP, holding 8.84% of the company's total share outstanding, currently valued at $46.76M. The top 10 institutional shareholders own together 39.74% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PARADIGM BIOCAPITAL ADVISORS LP8.84%1.79%3,870,5941,636,98473.29%46,756,776Jun 30, 2024
CALIGAN PARTNERS LP1.33%1.64%582,078-5,198-0.89%7,031,502Jun 30, 2024
SOFINNOVA INVESTMENTS, INC.5.01%1.38%2,194,278--26,506,878Jun 30, 2024
CORMORANT ASSET MANAGEMENT, LP3.31%1.01%1,450,0001,450,000100.00%17,516,000Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.1.48%0.69%647,98277,00013.49%7,827,623Jun 30, 2024
VIRTUS ETF ADVISERS LLC0.06%0.16%27,33227,332100.00%330,171Jun 30, 2024
POLAR CAPITAL HOLDINGS PLC4.18%0.13%1,831,000--22,118,480Jun 30, 2024
ENTRYPOINT CAPITAL, LLC0.01%0.11%6,1526,152100.00%74,316Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.84%0.11%369,36022,8496.59%4,461,869Jun 30, 2024
RICE HALL JAMES & ASSOCIATES, LLC0.20%0.07%89,7353,5894.17%1,083,999Jun 30, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC0.14%0.06%62,046-14,394-18.83%749,516Jun 30, 2024
SHERBROOKE PARK ADVISERS LLC0.05%0.05%23,64723,647100.00%285,656Jun 30, 2024
XTX TOPCO LTD0.06%0.03%24,62124,621100.00%297,422Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.17%0.02%76,00010,40015.85%918,080Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC0.74%0.01%323,175-279,139-46.34%3,902,000Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.0.82%0.01%358,945-1,168,155-76.50%4,336,056Jun 30, 2024
SAPIENT CAPITAL LLC0.10%0.01%43,700--527,896Jun 30, 2024
D. E. SHAW & CO., INC.2.12%0.01%926,457-141,702-13.27%11,191,601Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA1.51%0.01%659,672-86,429-11.58%7,968,838Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.40%0.01%176,055-26,019-12.88%2,126,744Jun 30, 2024

The largest Y-mAbs Therapeutics shareholder by % of total assets is PARADIGM BIOCAPITAL ADVISORS LP. The company owns 3.87M shares of Y-mAbs Therapeutics (YMAB), representing 1.79% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PARADIGM BIOCAPITAL ADVISORS LP8.84%1.79%3,870,5941,636,98473.29%46,756,776Jun 30, 2024
CORMORANT ASSET MANAGEMENT, LP3.31%1.01%1,450,0001,450,000100.00%17,516,000Jun 30, 2024
BLACKROCK INC.6.71%0.00%2,938,71881,4612.85%35,499,713Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.1.48%0.69%647,98277,00013.49%7,827,623Jun 30, 2024
SQUAREPOINT OPS LLC0.29%0.00%126,38974,452143.35%1,526,779Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.80%0.00%349,78467,23323.80%4,225,391Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP1.11%0.00%484,43165,73215.70%5,852,656Jun 30, 2024
SWISS NATIONAL BANK0.14%0.00%60,30060,300100.00%728,424,000Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC0.13%0.00%58,29958,299100.00%704,252Jun 30, 2024
STATE STREET CORP1.84%0.00%804,61253,5397.13%9,719,713,000Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.0.10%0.00%43,97343,973100.00%531,194Jun 30, 2024
ALPS ADVISORS INC0.08%0.00%34,22434,224100.00%413,426Jun 30, 2024
FRANKLIN RESOURCES INC0.15%0.00%66,97733,996103.08%809,081Jun 30, 2024
LEGAL & GENERAL GROUP PLC0.08%0.00%36,58133,2701004.83%441,899Jun 30, 2024
BANK OF AMERICA CORP /DE/0.10%-44,68331,546240.13%539,770Jun 30, 2024
VIRTUS ETF ADVISERS LLC0.06%0.16%27,33227,332100.00%330,171Jun 30, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM0.07%0.00%30,44926,749722.95%367,824Jun 30, 2024
XTX TOPCO LTD0.06%0.03%24,62124,621100.00%297,422Jun 30, 2024
SHERBROOKE PARK ADVISERS LLC0.05%0.05%23,64723,647100.00%285,656Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.75%0.00%765,64322,8943.08%9,250,856Jun 30, 2024

As of Jun 30 2024, Y-mAbs Therapeutics's largest institutional buyer is PARADIGM BIOCAPITAL ADVISORS LP. The company purchased 1.64M stocks of YMAB, valued at $46.76M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
POINT72 ASSET MANAGEMENT, L.P.0.82%0.01%358,945-1,168,155-76.50%4,336,056Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC0.74%0.01%323,175-279,139-46.34%3,902,000Jun 30, 2024
GOLDMAN SACHS GROUP INC0.32%0.00%138,739-226,797-62.05%1,675,967Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC0.26%0.00%112,483-155,247-57.99%1,358,795Jun 30, 2024
D. E. SHAW & CO., INC.2.12%0.01%926,457-141,702-13.27%11,191,601Jun 30, 2024
LOS ANGELES CAPITAL MANAGEMENT LLC----127,551-100.00%-Jun 30, 2024
VANGUARD GROUP INC4.47%0.00%1,957,339-112,178-5.42%23,644,655Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA1.51%0.01%659,672-86,429-11.58%7,968,838Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.02%0.00%6,597-71,189-91.52%79,695Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.15%0.00%64,637-50,663-43.94%780,815Jun 30, 2024
AMERICAN CENTURY COMPANIES INC----45,799-100.00%-Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.14%0.00%61,316-42,986-41.21%740,697Jun 30, 2024
BOSTON PARTNERS----34,165-100.00%-Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.40%0.01%176,055-26,019-12.88%2,126,744Jun 30, 2024
CAXTON ASSOCIATES LP----18,807-100.00%-Jun 30, 2024
UBS GROUP AG0.04%0.00%19,004-18,543-49.39%229,568Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----18,132-100.00%-Jun 30, 2024
VERITION FUND MANAGEMENT LLC----16,588-100.00%-Jun 30, 2024
HRT FINANCIAL LP----16,216-100.00%-Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC0.05%0.00%21,926-15,915-42.06%264,866Jun 30, 2024

As of Jun 30 2024, Y-mAbs Therapeutics's biggest institutional seller is POINT72 ASSET MANAGEMENT, L.P.. The company sold -1.17M shares of YMAB, valued at $4.34M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CORMORANT ASSET MANAGEMENT, LP3.31%1.01%1,450,0001,450,000100.00%17,516,000Jun 30, 2024
SWISS NATIONAL BANK0.14%0.00%60,30060,300100.00%728,424,000Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC0.13%0.00%58,29958,299100.00%704,252Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.0.10%0.00%43,97343,973100.00%531,194Jun 30, 2024
ALPS ADVISORS INC0.08%0.00%34,22434,224100.00%413,426Jun 30, 2024
VIRTUS ETF ADVISERS LLC0.06%0.16%27,33227,332100.00%330,171Jun 30, 2024
XTX TOPCO LTD0.06%0.03%24,62124,621100.00%297,422Jun 30, 2024
SHERBROOKE PARK ADVISERS LLC0.05%0.05%23,64723,647100.00%285,656Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.05%0.00%19,78719,787100.00%239,027Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.04%0.00%17,89717,897100.00%216,196Jun 30, 2024
JANUS HENDERSON GROUP PLC0.04%0.00%16,30016,300100.00%196,741Jun 30, 2024
GREAT WEST LIFE ASSURANCE CO /CAN/0.01%0.00%3,0483,048100.00%37,000Jun 30, 2024
SIGNATUREFD, LLC0.00%-6464100.00%773Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-3030100.00%362Jun 30, 2024
QUEST PARTNERS LLC--11100.00%12Jun 30, 2024

Y-mAbs Therapeutics's largest new institutional shareholder by number of shares is CORMORANT ASSET MANAGEMENT, LP, purchased 1.45M shares, valued at $17.52M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LOS ANGELES CAPITAL MANAGEMENT LLC----127,551-100.00%-Jun 30, 2024
AMERICAN CENTURY COMPANIES INC----45,799-100.00%-Jun 30, 2024
BOSTON PARTNERS----34,165-100.00%-Jun 30, 2024
CAXTON ASSOCIATES LP----18,807-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----18,132-100.00%-Jun 30, 2024
VERITION FUND MANAGEMENT LLC----16,588-100.00%-Jun 30, 2024
HRT FINANCIAL LP----16,216-100.00%-Jun 30, 2024
PRINCIPAL FINANCIAL GROUP INC----13,729-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----11,963-100.00%-Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.----6,019-100.00%-Jun 30, 2024
QUANTBOT TECHNOLOGIES LP----4,532-100.00%-Jun 30, 2024
AQUATIC CAPITAL MANAGEMENT LLC----3,300-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----2,055-100.00%-Jun 30, 2024
TUCKER ASSET MANAGEMENT LLC----1,200-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----8-100.00%-Jun 30, 2024

Y-mAbs Therapeutics's largest sold out institutional shareholder by shares sold is LOS ANGELES CAPITAL MANAGEMENT LLC, sold -0.13M shares, valued at -, as of undefined.

Y-mAbs Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
HARTFORD HLS SERIES FUND II INC0.69%169,127--Dec 31, 2023
TEKLA HEALTHCARE INVESTORS0.16%135,765--Mar 31, 2024
TEKLA LIFE SCIENCES INVESTORS0.13%62,055--Mar 31, 2024
VANGUARD EXPLORER FUND0.13%1,621,623--Jan 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.10%330,836--Mar 31, 2024
PUTNAM GLOBAL HEALTH CARE FUND0.08%125,186--Feb 29, 2024
VANGUARD VALLEY FORGE FUNDS0.05%25,975--Mar 31, 2024
Humankind Benefit Corp0.04%939--Dec 31, 2023
T. Rowe Price New Horizons Fund, Inc.0.03%145,207--Mar 31, 2024
IndexIQ ETF Trust0.03%65,365-4,005-5.77%Jan 31, 2024
BRIDGEWAY FUNDS INC0.03%65,600-30,000-31.38%Mar 28, 2024
FIDELITY SELECT PORTFOLIOS0.03%1,740,751--Feb 29, 2024
AB CAP FUND, INC.0.03%869,352--Jan 31, 2024
FIDELITY ADVISOR SERIES VII0.02%194,803--Jan 31, 2024
Federated Hermes MDT Series0.02%44,474--Jan 31, 2024
ETFis Series Trust I0.01%20,612--Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%63,965--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%5,581--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.01%29,763--Feb 29, 2024
T. Rowe Price Equity Series, Inc.0.01%15,065--Mar 31, 2024
Bernstein Fund Inc0.01%54,259--Mar 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.01%21,799-6,825-23.84%Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%959--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%1,623,095-470,587-22.48%Mar 31, 2024
Nushares ETF Trust0.00%27,552--Jan 31, 2024
DRIEHAUS MUTUAL FUNDS0.00%32,751--Mar 28, 2024
AB VARIABLE PRODUCTS SERIES FUND, INC.0.00%15,744--Mar 31, 2024
ALPS ETF Trust0.00%42,317--Feb 29, 2024
Fidelity Commonwealth Trust II0.00%21,928--Aug 31, 2023
JNL VARIABLE FUND LLC0.00%15,199--Mar 31, 2020
SCHWAB CAPITAL TRUST0.00%99,319-4,727-4.54%Jan 31, 2024
VICTORY PORTFOLIOS0.00%62,720--Mar 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%103,404--Mar 31, 2024
North Square Investments Trust0.00%16,280--Jan 31, 2024
CLEARWATER INVESTMENT TRUST0.00%15,6304933.26%Mar 28, 2024
ETF Series Solutions0.00%33,0555,29619.08%Feb 29, 2024
MML SERIES INVESTMENT FUND0.00%14,253--Dec 31, 2023
HARTFORD SERIES FUND INC0.00%60,027--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%290,00110,6203.80%Feb 29, 2024
Calvert Variable Products, Inc.0.00%3,7011,05639.92%Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%14,1801531.09%Mar 31, 2024
Managed Portfolio Series0.00%24,560--Jan 31, 2024
MFS VARIABLE INSURANCE TRUST III0.00%16,131-655-3.90%Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%79,690--Jan 31, 2024
NORTHWESTERN MUTUAL SERIES FUND INC0.00%102,833--Mar 31, 2024
GPS Funds I0.00%4,799--Mar 31, 2024
Lattice Strategies Trust0.00%1,2191,219-Mar 31, 2024
VANGUARD HORIZON FUNDS0.00%18,518-267,792-93.53%Mar 31, 2024
Principal Exchange-Traded Funds0.00%9,130-1,114-10.87%Mar 31, 2024
Direxion Shares ETF Trust0.00%109,514--Jan 31, 2024
NEW COVENANT FUNDS0.00%3,117--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%21,582-1,583-6.83%Mar 31, 2024
FIDELITY COVINGTON TRUST0.00%12,959-8,969-40.90%Mar 31, 2024
HARTFORD MUTUAL FUNDS II INC0.00%109,120--Jan 31, 2024
ARTISAN PARTNERS FUNDS INC0.00%1,017,009--Mar 31, 2024
Global X Funds0.00%25,001--Jan 31, 2024
PUTNAM FUNDS TRUST0.00%108,000--Jan 31, 2024
VANGUARD WORLD FUND0.00%119,1506080.51%Feb 29, 2024
SunAmerica Specialty Series0.00%247--Apr 30, 2021
PRUDENTIAL INVESTMENT PORTFOLIOS, INC.0.00%4,300--Mar 28, 2024
VANGUARD QUANTITATIVE FUNDS0.00%2,100--Mar 31, 2024
HC CAPITAL TRUST0.00%14,136--Mar 31, 2024
Meeder Funds0.00%1,867--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%12,190-3,415-21.88%Mar 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%47,298-24,108-33.76%Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,660-462-21.77%Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%33,0469,81442.24%Feb 29, 2024
AMG FUNDS III0.00%1,451--Mar 28, 2024
SCHWAB STRATEGIC TRUST0.00%152,3775,0893.46%Feb 29, 2024
OHIO NATIONAL FUND INC0.00%4,746--Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%616--Mar 31, 2024
RBB FUND, INC.0.00%19,929--Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%13,2001,1009.09%Mar 31, 2024
NORTHERN FUNDS0.00%26,911-917-3.30%Mar 28, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%190,72245,34731.19%Jan 31, 2024
LOOMIS SAYLES FUNDS II0.00%466,773--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%21,7058,02958.71%Jan 31, 2024
Trust for Advised Portfolios0.00%2,952--Dec 31, 2023
PUTNAM VARIABLE TRUST0.00%5,115--Mar 31, 2024
Dimensional ETF Trust0.00%59,71318,47344.79%Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%143,055-124,580-46.55%Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%2,342984.37%Mar 31, 2024
OLD WESTBURY FUNDS INC0.00%13,484--Jan 31, 2024
EQ ADVISORS TRUST0.00%124,439-5,267-4.06%Mar 31, 2024
iSHARES TRUST0.00%1,623,982-54,529-3.25%Mar 31, 2024
ALLSPRING MASTER TRUST0.00%6,352--Feb 29, 2024
FundVantage Trust0.00%1,354--Mar 28, 2024
Goldman Sachs ETF Trust0.00%8,483-2,568-23.24%Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%165,90719,71013.48%Feb 29, 2024
RYDEX SERIES FUNDS0.00%336--Dec 31, 2023
JPMORGAN INSURANCE TRUST0.00%900--Mar 31, 2023
PACE SELECT ADVISORS TRUST0.00%19,058--Jan 31, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%169,44027,84019.66%Dec 31, 2023
FLEXSHARES TRUST0.00%4,278--Jan 31, 2024
SA FUNDS INVESTMENT TRUST0.00%802--Mar 31, 2024
VALIC Co I0.00%14,119-57-0.40%Feb 29, 2024
GOLDMAN SACHS TRUST0.00%161,4164,1992.67%Jan 31, 2024
TIAA-CREF FUNDS0.00%129,859--Jan 31, 2024
PENN SERIES FUNDS INC0.00%1,200--Mar 28, 2024
RYDEX DYNAMIC FUNDS0.00%166--Dec 31, 2023

Y-mAbs Therapeutics's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 169.13K shares, compromising 0.69% of its total assets.

Y-mAbs Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2434-65.66%
31 Mar, 24996.45%
31 Dec, 2393-5.10%
30 Sep, 23981.03%
30 Jun, 239712.79%
31 Mar, 2386-6.52%
31 Dec, 2292-9.80%
30 Sep, 221028.51%
30 Jun, 22944.44%
31 Mar, 2290-4.26%
31 Dec, 2194-4.08%
30 Sep, 2198-1.01%
30 Jun, 2199-16.10%
31 Mar, 211184.42%
31 Dec, 201136.60%
30 Sep, 20106-2.75%
30 Jun, 2010936.25%
31 Mar, 2080-1.23%
31 Dec, 198124.62%
30 Sep, 196510.17%
30 Jun, 195934.09%
31 Mar, 19444.76%
31 Dec, 184210.53%
30 Sep, 1838-

As of 30 Jun 24, 34 institutions are holding Y-mAbs Therapeutics's shares, representing a decrease of -65.66% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 245,015,244-78.20%
31 Mar, 2423,007,88413.95%
31 Dec, 2320,191,0852.81%
30 Sep, 2319,640,023-0.74%
30 Jun, 2319,785,4954.10%
31 Mar, 2319,006,537-1.62%
31 Dec, 2219,319,778-18.00%
30 Sep, 2223,559,613-4.86%
30 Jun, 2224,763,575-2.11%
31 Mar, 2225,296,943-1.67%
31 Dec, 2125,725,752-1.94%
30 Sep, 2126,235,2200.38%
30 Jun, 2126,135,469-1.40%
31 Mar, 2126,505,86818.00%
31 Dec, 2022,461,8394.77%
30 Sep, 2021,438,9120.73%
30 Jun, 2021,284,3386.05%
31 Mar, 2020,069,8093.43%
31 Dec, 1919,404,46547.68%
30 Sep, 1913,139,73919.75%
30 Jun, 1910,972,46029.39%
31 Mar, 198,480,260-2.37%
31 Dec, 188,686,03312.32%
30 Sep, 187,733,371-

Y-mAbs Therapeutics (YMAB) has 5.02M shares outstanding as of 30 Jun 24, down -78.20% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2411.46%0.41%
31 Mar, 2452.74%2.46%
31 Dec, 2346.29%2.29%
30 Sep, 2344.98%2.19%
30 Jun, 2345.31%2.39%
31 Mar, 2343.52%2.23%
31 Dec, 2244.21%1.52%
30 Sep, 2253.89%1.68%
30 Jun, 2256.64%1.69%
31 Mar, 2257.88%1.63%
31 Dec, 2159.58%1.65%
30 Sep, 2160.17%1.67%
30 Jun, 2159.99%1.50%
31 Mar, 2163.30%2.02%
31 Dec, 2055.99%1.97%
30 Sep, 2053.35%1.88%
30 Jun, 2053.25%2.09%
31 Mar, 2050.49%2.12%
31 Dec, 1948.81%3.34%
30 Sep, 1938.23%3.71%
30 Jun, 1932.09%5.22%
31 Mar, 1924.80%2.72%
31 Dec, 1830.19%3.77%
30 Sep, 1828.30%-

As of 30 Jun 24, Y-mAbs Therapeutics is held by 11.46% institutional shareholders, representing a 0.41% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2417-62.22%
31 Mar, 2445-4.26%
31 Dec, 234720.51%
30 Sep, 2339-26.42%
30 Jun, 235312.77%
31 Mar, 23476.82%
31 Dec, 22444.76%
30 Sep, 2242-16.00%
30 Jun, 225016.28%
31 Mar, 2243-17.31%
31 Dec, 21524.00%
30 Sep, 2150-15.25%
30 Jun, 2159-20.27%
31 Mar, 217419.35%
31 Dec, 206219.23%
30 Sep, 2052-28.77%
30 Jun, 207387.18%
31 Mar, 2039-40.91%
31 Dec, 196669.23%
30 Sep, 1939-13.33%
30 Jun, 1945136.84%
31 Mar, 1919-29.63%
31 Dec, 1827-28.95%
30 Sep, 1838-

17 institutional shareholders have increased their position in YMAB stock as of 30 Jun 24 compared to 45 in the previous quarter (a -62.22% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2410-76.74%
31 Mar, 244338.71%
31 Dec, 2331-16.22%
30 Sep, 233719.35%
30 Jun, 233129.17%
31 Mar, 2324-27.27%
31 Dec, 2233-5.71%
30 Sep, 223540.00%
30 Jun, 2225-19.35%
31 Mar, 223110.71%
31 Dec, 2128-9.68%
30 Sep, 213147.62%
30 Jun, 2121-34.38%
31 Mar, 2132-5.88%
31 Dec, 2034-10.53%
30 Sep, 203831.03%
30 Jun, 2029-6.45%
31 Mar, 2031244.44%
31 Dec, 199-35.71%
30 Sep, 191455.56%
30 Jun, 199-35.71%
31 Mar, 191440.00%
31 Dec, 1810-
30 Sep, 18--

10 institutional shareholders have reduced their position in YMAB stock as of 30 Jun 24 compared to 43 in the previous quarter (a -76.74% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2434-65.66%5,015,244-78.20%11.46%0.41%17-62.22%10-76.74%
31 Mar, 24996.45%23,007,88413.95%52.74%2.46%45-4.26%4338.71%
31 Dec, 2393-5.10%20,191,0852.81%46.29%2.29%4720.51%31-16.22%
30 Sep, 23981.03%19,640,023-0.74%44.98%2.19%39-26.42%3719.35%
30 Jun, 239712.79%19,785,4954.10%45.31%2.39%5312.77%3129.17%
31 Mar, 2386-6.52%19,006,537-1.62%43.52%2.23%476.82%24-27.27%
31 Dec, 2292-9.80%19,319,778-18.00%44.21%1.52%444.76%33-5.71%
30 Sep, 221028.51%23,559,613-4.86%53.89%1.68%42-16.00%3540.00%
30 Jun, 22944.44%24,763,575-2.11%56.64%1.69%5016.28%25-19.35%
31 Mar, 2290-4.26%25,296,943-1.67%57.88%1.63%43-17.31%3110.71%
31 Dec, 2194-4.08%25,725,752-1.94%59.58%1.65%524.00%28-9.68%
30 Sep, 2198-1.01%26,235,2200.38%60.17%1.67%50-15.25%3147.62%
30 Jun, 2199-16.10%26,135,469-1.40%59.99%1.50%59-20.27%21-34.38%
31 Mar, 211184.42%26,505,86818.00%63.30%2.02%7419.35%32-5.88%
31 Dec, 201136.60%22,461,8394.77%55.99%1.97%6219.23%34-10.53%
30 Sep, 20106-2.75%21,438,9120.73%53.35%1.88%52-28.77%3831.03%
30 Jun, 2010936.25%21,284,3386.05%53.25%2.09%7387.18%29-6.45%
31 Mar, 2080-1.23%20,069,8093.43%50.49%2.12%39-40.91%31244.44%
31 Dec, 198124.62%19,404,46547.68%48.81%3.34%6669.23%9-35.71%
30 Sep, 196510.17%13,139,73919.75%38.23%3.71%39-13.33%1455.56%
30 Jun, 195934.09%10,972,46029.39%32.09%5.22%45136.84%9-35.71%
31 Mar, 19444.76%8,480,260-2.37%24.80%2.72%19-29.63%1440.00%
31 Dec, 184210.53%8,686,03312.32%30.19%3.77%27-28.95%10-
30 Sep, 1838-7,733,371-28.30%-38---

Y-mAbs Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 11, 2024Ber Gerarddirector-S-SaleSell722$12.00$8.66K1,608
Jun 11, 2024Gad Thomasdirector, officer CHIEF BUSINESS OFFICERS-SaleSell35,000$12.03$421.05K197,681
Jun 11, 2024Gad Thomasdirector, officer CHIEF BUSINESS OFFICERS-SaleSell35,000$12.00$420.00K162,681

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 11, 2024Ber Gerarddirector-S-SaleSell722$12.00$8.66K1,608
Jun 11, 2024Gad Thomasdirector, officer CHIEF BUSINESS OFFICERS-SaleSell35,000$12.03$421.05K197,681
Jun 11, 2024Gad Thomasdirector, officer CHIEF BUSINESS OFFICERS-SaleSell35,000$12.00$420.00K162,681
May 31, 2024Kruse Boofficer EVP, CFO, SECRY & TREAS.M-ExemptSell28,629$2.00$57.26K271,371

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 12, 2024PFREUNDSCHUH PETER P.officer CFO and TreasurerA-AwardBuy170,000$12.47$2.12M170,000
Jul 12, 2024PFREUNDSCHUH PETER P.officer CFO and TreasurerA-AwardBuy46,000--46,000
Jul 08, 2024PFREUNDSCHUH PETER P.-Buy----
Jun 13, 2024TAGLIAFERRI MARYdirector-A-AwardBuy14,545$12.01$174.69K14,545
Jun 13, 2024TAGLIAFERRI MARYdirector-A-AwardBuy3,495--8,155
Jun 13, 2024Hamill Lauradirector-A-AwardBuy14,545$12.01$174.69K14,545
Jun 13, 2024Hamill Lauradirector-A-AwardBuy3,495--5,825
Jun 13, 2024Wedell-Wedellsborg Johandirector, 10 percent owner A-AwardBuy14,545$12.01$174.69K14,545
Jun 13, 2024Wedell-Wedellsborg Johandirector, 10 percent owner A-AwardBuy3,495--5,825
Jun 13, 2024HEALY JAMESdirector-A-AwardBuy3,495--31,603
Jun 13, 2024HEALY JAMESdirector-A-AwardBuy14,545$12.01$174.69K14,545
Jun 13, 2024GILL DAVID Ndirector-A-AwardBuy14,545$12.01$174.69K14,545
Jun 13, 2024GILL DAVID Ndirector-A-AwardBuy3,495--5,825
Jun 13, 2024TYAGI ASHUdirector-A-AwardBuy14,545$12.01$174.69K14,545
Jun 13, 2024TYAGI ASHUdirector-A-AwardBuy3,495--5,825
Jun 11, 2024Ber Gerarddirector-S-SaleSell722$12.00$8.66K1,608
Jun 11, 2024Gad Thomasdirector, officer CHIEF BUSINESS OFFICERS-SaleSell35,000$12.03$421.05K197,681
Jun 11, 2024Gad Thomasdirector, officer CHIEF BUSINESS OFFICERS-SaleSell35,000$12.00$420.00K162,681
May 31, 2024Kruse Boofficer EVP, CFO, SECRY & TREAS.M-ExemptSell28,629$2.00$57.26K271,371
May 31, 2024Kruse Boofficer EVP, CFO, SECRY & TREAS.M-ExemptBuy31,371$2.00$62.74K242,248

The last insider sell of Y-mAbs Therapeutics's stock was made by Ber Gerard on Jun 11 2024, selling 722 shares at $12.00 per share (valued at $8.66K).

Y-mAbs Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20242--
Q2 2024149155.56%
Q1 2024193633.33%
Q4 2023176283.33%
Q2 202314--
Q1 202319--
Q4 20221--
Q3 202212--
Q2 202210--
Q1 202222010.00%
Q4 2021102050.00%
Q3 202121711.76%
Q2 202193129.03%
Q1 202182138.10%
Q4 2020152075.00%
Q3 202031421.43%
Q2 202091850.00%
Q1 202061540.00%
Q4 20195955.56%
Q3 2019-20-

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Y-mAbs Therapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2024-7-
Q1 2024-3-
Q4 2023145280.00%
Q2 20232--
Q1 2023---
Q4 20221--
Q3 2022---
Q2 2022---
Q1 2022-18-
Q4 2021-18-
Q3 20211166.25%
Q2 2021-28-
Q1 2021-13-
Q4 202021414.29%
Q3 2020-11-
Q2 2020-18-
Q1 20201616.67%
Q4 20191616.67%
Q3 2019-18-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Y-mAbs Therapeutics's stocks.

Y-mAbs Therapeutics Peer Ownership


TickerCompany
VECTVectivBio Holding AG
ZNTLZentalis Pharmaceuticals, Inc.
RVMDRevolution Medicines, Inc. Warrant
MRUSMerus N.V.
LRMRLarimar Therapeutics, Inc.
EWTXEdgewise Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
ERASErasca, Inc.
BLUEbluebird bio, Inc.
TVTXTravere Therapeutics, Inc.
STROSutro Biopharma, Inc.
ARQTArcutis Biotherapeutics, Inc.
GBIOGeneration Bio Co.
BDTXBlack Diamond Therapeutics, Inc.
BCELAtreca, Inc.
SNDXSyndax Pharmaceuticals, Inc.
KRONKronos Bio, Inc.
PASGPassage Bio, Inc.
CCCCC4 Therapeutics, Inc.
MRSNMersana Therapeutics, Inc.
PCVXVaxcyte, Inc.
MIRMMirum Pharmaceuticals, Inc.

YMAB Ownership FAQ


Y-mAbs Therapeutics is owned by institutional shareholders (11.46%), insiders (12.27%), and public (76.28%). The largest institutional shareholder of Y-mAbs Therapeutics is PARADIGM BIOCAPITAL ADVISORS LP (8.84% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (0.69% of total shares).

Y-mAbs Therapeutics's major institutional shareholders are PARADIGM BIOCAPITAL ADVISORS LP, BLACKROCK INC., SOFINNOVA INVESTMENTS, INC., VANGUARD GROUP INC, and POLAR CAPITAL HOLDINGS PLC. The top five shareholders own together 29.22% of the company's share outstanding.

As of Jun 2024, there are 34 institutional shareholders of Y-mAbs Therapeutics.

PARADIGM BIOCAPITAL ADVISORS LP owns 3.87M shares of Y-mAbs Therapeutics, representing 8.84% of the company's total shares outstanding, valued at $46.76M (as of Jun 2024).

As of Jun 2024, BLACKROCK INC holds 2.94M shares of Y-mAbs Therapeutics (YMAB), compromising 6.71% of the company, valued at $35.5M.

SOFINNOVA INVESTMENTS, INC is the third largest holder of Y-mAbs Therapeutics. The company owns 2.19M of the company's shares outstanding (worth $26.51M).